Elliot Zemel - 31 Mar 2025 Form 3 Insider Report for CANNAPHARMARX, INC. (CPMD)

Role: Director
Signature: /s/ Elliot Zemel
Issuer symbol: CPMD
Transactions as of: 31 Mar 2025
Net transactions value: $0
Form type: 3
Filing time: 10 Apr 2025, 21:42:49 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CPMD	Common shares						23,368,212	31 Mar 2025	Koze Investments LLC is a company that may be deemed to be owned by Elliot Zemel

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Ownership	Footnotes
holding	CPMD	Series C Preferred	31 Mar 2025	Common Stock	Koze Investments LLC is a company that may be deemed to be owned by Elliot Zemel	F1
holding	CPMD	Warrants	31 Mar 2025	Common Stock	Koze Investments LLC is a company that may be deemed to be owned by Elliot Zemel	F1
holding	CPMD	Convertible notes	31 Mar 2025	Common Stock	Koze Investments LLC is a company that may be deemed to be owned by Elliot Zemel	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Under the terms of the LTB transaction with the Issuer, Koze Investments LLC was issued: (i) 1,3612,481 warrants entitling the holder to purchase one share of common stock of the Company at $0.02 per share until November 22, 2028; (ii) $2,550,000 in promissory notes payable to Koze Investments (iii) $68,555.43 in convertible notes at an exercise price of the lowest 60 day share price before the period end; and (iv) 100,000 Class C preferred shares each convertible into 1,250 shares of common stock. Mr. Zemel is not permitted to, at any time, to own more than 4.99% of the outstanding shares of common stock of the Company.

Content

Under the terms of the LTB transaction with the Issuer, Koze Investments LLC was issued: (i) 1,3612,481 warrants entitling the holder to purchase one share of common stock of the Company at $0.02 per share until November 22, 2028; (ii) $2,550,000 in promissory notes payable to Koze Investments (iii) $68,555.43 in convertible notes at an exercise price of the lowest 60 day share price before the period end; and (iv) 100,000 Class C preferred shares each convertible into 1,250 shares of common stock. Mr. Zemel is not permitted to, at any time, to own more than 4.99% of the outstanding shares of common stock of the Company.